BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 18249215)

  • 1. Increased total and high-molecular weight adiponectin after extended-release niacin.
    Plaisance EP; Grandjean PW; Brunson BL; Judd RL
    Metabolism; 2008 Mar; 57(3):404-9. PubMed ID: 18249215
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High molecular weight multimer form of adiponectin as a useful marker to evaluate insulin resistance and metabolic syndrome in Japanese men.
    Seino Y; Hirose H; Saito I; Itoh H
    Metabolism; 2007 Nov; 56(11):1493-9. PubMed ID: 17950099
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adiponectin multimeric complexes and the metabolic syndrome trait cluster.
    Lara-Castro C; Luo N; Wallace P; Klein RL; Garvey WT
    Diabetes; 2006 Jan; 55(1):249-59. PubMed ID: 16380500
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-molecular-weight adiponectin is a predictor of progression to metabolic syndrome: a population-based 6-year follow-up study in Japanese men.
    Seino Y; Hirose H; Saito I; Itoh H
    Metabolism; 2009 Mar; 58(3):355-60. PubMed ID: 19217451
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Extended-release niacin decreases serum fetuin-A concentrations in individuals with metabolic syndrome.
    Kaushik SV; Plaisance EP; Kim T; Huang EY; Mahurin AJ; Grandjean PW; Mathews ST
    Diabetes Metab Res Rev; 2009 Jul; 25(5):427-34. PubMed ID: 19405044
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of losartan on serum total and high-molecular weight adiponectin concentrations in hypertensive patients with metabolic syndrome.
    Uchida T; Shimizu M; Sakai Y; Nakano T; Hara K; Takebayashi K; Inoue T; Node K; Inukai T; Takayanagi K; Aso Y
    Metabolism; 2008 Sep; 57(9):1278-85. PubMed ID: 18702955
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preferential increase in high-molecular weight adiponectin after niacin.
    Westphal S; Luley C
    Atherosclerosis; 2008 May; 198(1):179-83. PubMed ID: 17996241
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of serum high-molecular weight (HMW) adiponectin with total adiponectin concentrations in type 2 diabetic patients with coronary artery disease using a novel enzyme-linked immunosorbent assay to detect HMW adiponectin.
    Aso Y; Yamamoto R; Wakabayashi S; Uchida T; Takayanagi K; Takebayashi K; Okuno T; Inoue T; Node K; Tobe T; Inukai T; Nakano Y
    Diabetes; 2006 Jul; 55(7):1954-60. PubMed ID: 16804063
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes in adiponectin multimer distribution in response to atorvastatin treatment in patients with type 2 diabetes.
    von Eynatten M; Liu D; Bluemm A; Schuster T; Baumann M; Lutz J; Heemann U; Dugi KA; Nawroth PP; Bierhaus A; Humpert PM
    Clin Endocrinol (Oxf); 2009 Jul; 71(1):27-32. PubMed ID: 18778396
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High molecular weight adiponectin correlates positively with myeloperoxidase in patients with type 2 diabetes mellitus.
    Bobbert P; Rauch U; Stratmann B; Goldin-Lang P; Antoniak S; Bobbert T; Schultheiss HP; Tschoepe D
    Diabetes Res Clin Pract; 2008 Nov; 82(2):179-84. PubMed ID: 18778866
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of obesity and insulin sensitivity on adiponectin isoform distribution.
    Kaser S; Tatarczyk T; Stadlmayr A; Ciardi C; Ress C; Tschoner A; Sandhofer A; Paulweber B; Ebenbichler CF; Patsch JR
    Eur J Clin Invest; 2008 Nov; 38(11):827-34. PubMed ID: 19021700
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Measurement of the high-molecular weight form of adiponectin in plasma is useful for the prediction of insulin resistance and metabolic syndrome.
    Hara K; Horikoshi M; Yamauchi T; Yago H; Miyazaki O; Ebinuma H; Imai Y; Nagai R; Kadowaki T
    Diabetes Care; 2006 Jun; 29(6):1357-62. PubMed ID: 16732021
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum high-molecular weight adiponectin decreases abruptly after an oral glucose load in subjects with normal glucose tolerance or impaired fasting glucose, but not those with impaired glucose tolerance or diabetes mellitus.
    Ozeki N; Hara K; Yatsuka C; Nakano T; Matsumoto S; Suetsugu M; Nakamachi T; Takebayashi K; Inukai T; Haruki K; Aso Y
    Metabolism; 2009 Oct; 58(10):1470-6. PubMed ID: 19592051
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-molecular weight adiponectin isoforms increase after biliopancreatic diversion in obese subjects.
    Salani B; Briatore L; Andraghetti G; Adami GF; Maggi D; Cordera R
    Obesity (Silver Spring); 2006 Sep; 14(9):1511-4. PubMed ID: 17030961
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum total and high molecular weight adiponectin levels are correlated with the severity of diabetic retinopathy and nephropathy.
    Kato K; Osawa H; Ochi M; Kusunoki Y; Ebisui O; Ohno K; Ohashi J; Shimizu I; Fujii Y; Tanimoto M; Makino H
    Clin Endocrinol (Oxf); 2008 Mar; 68(3):442-9. PubMed ID: 17970779
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Type 2 diabetes in octogenarians is associated with decreased low molecular weight adiponectin.
    Graessler J; Gruber M; Radke RB; Kopprasch S; Schwarz PE; Kamke W; Bornstein SR; Fischer S
    Gerontology; 2011; 57(4):316-26. PubMed ID: 20551622
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adiponectin multimer distribution, not absolute amount of plasma, correlates with depression severity in healthy elderly subjects.
    Narita K; Murata T; Hamada T; Takahashi T; Kosaka H; Sudo S; Mizukami K; Yoshida H; Wada Y
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Jan; 32(1):124-7. PubMed ID: 17761380
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selective downregulation of the high molecular weight form of adiponectin in hyperinsulinemia and in type 2 diabetes: differential regulation from nondiabetic subjects.
    Basu R; Pajvani UB; Rizza RA; Scherer PE
    Diabetes; 2007 Aug; 56(8):2174-7. PubMed ID: 17513700
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A lack of increase in high molecular weight-adiponectin in macroalbuminuric subjects with metabolic syndrome may exert renal and atherosclerotic risks.
    Tsuda S; Nakano S; Konishi K; Koya D
    Diabetes Res Clin Pract; 2008 Mar; 79(3):503-9. PubMed ID: 18006102
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-molecular-weight adiponectin does not predict cardiovascular events in patients with type 2 diabetes.
    Krzyzanowska K; Aso Y; Mittermayer F; Inukai T; Brix J; Schernthaner G
    Transl Res; 2009 Apr; 153(4):199-203. PubMed ID: 19304279
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.